Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Diagnosis and prevention of pertussis.

Preston NW.

Lancet. 2006 Nov 18;368(9549):1769; author reply 1769-70. No abstract available.

PMID:
17113422
2.

Eradication of poliomyelitis.

Preston NW.

Lancet. 2005 Oct 1;366(9492):1164. No abstract available.

PMID:
16198764
3.

Prevention of cholera.

Preston NW.

Lancet. 2004 Mar 13;363(9412):898. No abstract available.

PMID:
15031046
4.

Why the rise in Haemophilus influenzae type b infections?

Preston NW.

Lancet. 2003 Jul 26;362(9380):330-1. No abstract available.

PMID:
12892973
5.

Surveillance of whooping cough should continue.

Matthews RC, Preston NW, Holden DJ.

BMJ. 2002 Oct 19;325(7369):904. No abstract available.

6.

Current pharmacotherapy of pertussis.

Kerr JR, Preston NW.

Expert Opin Pharmacother. 2001 Aug;2(8):1275-82. Review.

PMID:
11584995
7.

Pertussis vaccine efficacy in Birmingham.

Preston NW.

Commun Dis Public Health. 2000 Sep;3(3):219-20. No abstract available.

PMID:
11014042
8.

Promiscuity and the abuse of stigma.

Preston NW.

Lancet. 2000 Feb 19;355(9204):659. No abstract available.

PMID:
10697012
9.

Acellular pertussis vaccines: progress but déjà vu.

Preston NW, Matthews RC.

Lancet. 1998 Jun 13;351(9118):1811-2. No abstract available.

PMID:
9635974
10.

Vaccination and the eradication of infectious diseases.

Preston NW.

Natl Med J India. 1997 Sep-Oct;10(5):205-8. No abstract available.

11.

Cholera vaccines: lessons from Rwanda and elsewhere.

Preston NW.

Lancet. 1997 Mar 29;349(9056):957. No abstract available.

PMID:
9093279
12.

Toxoid vaccine for pertussis.

Preston NW, Matthews RC.

Lancet. 1997 Jan 11;349(9045):137; author reply 137-8. No abstract available.

PMID:
8996452
13.

Components of acellular pertussis vaccines.

Preston NW, Matthews RC.

Lancet. 1996 Mar 16;347(9003):764. No abstract available.

PMID:
8602023
14.

Transmission of pertussis: do adults have an important role?

Preston NW, Matthews RC.

Lancet. 1996 Jan 13;347(8994):129-30. No abstract available.

PMID:
8538333
15.

Application of pulsed field gel electrophoresis to the 1993 epidemic of whooping cough in the UK.

Syedabubakar SN, Matthews RC, Preston NW, Owen D, Hillier V.

Epidemiol Infect. 1995 Aug;115(1):101-13.

16.

Measles and pertussis: the timing of vaccination.

Preston NW.

Lancet. 1995 Apr 1;345(8953):858-9. No abstract available.

PMID:
7898244
17.

Immunological and bacteriological distinction between parapertussis and pertussis.

Preston NW, Matthews RC.

Lancet. 1995 Feb 18;345(8947):463-4. No abstract available.

PMID:
7853990
18.

Polio eradication.

Preston NW.

Lancet. 1994 Oct 22;344(8930):1163. No abstract available.

PMID:
7934523
19.

Cholera treatment.

Preston NW.

Lancet. 1994 Oct 8;344(8928):1022. No abstract available.

PMID:
7934402
20.

Pertussis vaccination: neither panic nor complacency.

Preston NW.

Lancet. 1994 Aug 20;344(8921):491-2. No abstract available.

PMID:
7914610
21.

Immunisation of the preterm baby.

Preston NW.

J Infect. 1994 Mar;28(2):230-2. No abstract available.

PMID:
8035005
22.

Characterization of outbreak and vaccine strains of Bordetella pertussis--Quebec.

Knowles K, Lorange M, Matthews RC, Preston NW.

Can Commun Dis Rep. 1993 Nov 15;19(21):182-3, 186-7. English, French. No abstract available.

PMID:
8298581
23.

Cholera isolates in relation to the "eighth pandemic".

Preston NW.

Lancet. 1993 Oct 9;342(8876):925-6. No abstract available.

PMID:
8105182
25.

Publication bias via suppressed expert conflict.

Preston NW.

Lancet. 1993 Apr 17;341(8851):1031. No abstract available.

PMID:
8096921
26.

Measles control in young infants.

Preston NW.

Lancet. 1993 Mar 13;341(8846):688-9. No abstract available.

PMID:
8095588
27.

Eradication by vaccination: the memorial to smallpox could be surrounded by others.

Preston NW.

Prog Drug Res. 1993;41:151-89. Review. No abstract available.

PMID:
8108558
28.

Serotype specificity of vaccine-induced immunity to pertussis.

Preston NW, Carter EJ.

Commun Dis Rep CDR Rev. 1992 Dec 4;2(13):R155-6.

PMID:
1285135
29.

Diphtheria, pertussis, and tetanus vaccination.

Preston NW.

Lancet. 1992 May 30;339(8805):1356. No abstract available.

PMID:
1350015
30.

Typhoid vaccine and laboratory indicators of clinical protection.

Preston NW.

Lancet. 1992 Feb 29;339(8792):555. No abstract available.

PMID:
1346904
31.

Assessing the response to pertussis vaccine.

Preston NW.

BMJ. 1991 Nov 9;303(6811):1204. No abstract available.

32.

Accelerated immunisation with diphtheria-tetanus-pertussis vaccine.

Preston NW.

BMJ. 1991 Jul 27;303(6796):248. No abstract available.

33.

Antigens that modern vaccines must contain.

Preston NW.

Lancet. 1990 Sep 22;336(8717):756-7. No abstract available.

PMID:
1975932
34.

Location of the three major agglutinogens of Bordetella pertussis by immuno-electronmicroscopy.

Preston NW, Zorgani AA, Carter EJ.

J Med Microbiol. 1990 May;32(1):63-8.

PMID:
1971311
35.

Whooping cough in Stuttgart.

Enders G, Rapp I, Biber M, Preston NW, Carter EJ.

Lancet. 1988 May 14;1(8594):1113. No abstract available.

PMID:
2896947
36.

Eradication of pertussis by vaccination.

Preston NW.

Lancet. 1987 Jun 6;1(8545):1312. No abstract available.

PMID:
2884427
37.

Recognising whooping cough.

Preston NW.

Br Med J (Clin Res Ed). 1986 Mar 29;292(6524):901-2. No abstract available.

38.

Whooping cough in West Germany.

Hoppe JE, Preston NW.

Lancet. 1985 Oct 5;2(8458):776. No abstract available.

PMID:
2864505
39.

Change in serotype of pertussis infection in Britain.

Preston NW.

Lancet. 1985 Mar 2;1(8427):510. No abstract available.

PMID:
2857864
40.

Essential immunogens in human pertussis: the role of fimbriae.

Preston NW.

Dev Biol Stand. 1985;61:137-41.

PMID:
2872099
41.

Association between Bordetella pertussis agglutinogen 2 and fimbriae.

Carter EJ, Preston NW.

J Med Microbiol. 1984 Aug;18(1):87-94.

PMID:
6146723
42.

Centenary of the Gram-stain.

Preston NW.

J Infect. 1984 May;8(3):277-8. No abstract available.

PMID:
6203985
43.

Vibrio cholerae in South America.

Preston NW.

Lancet. 1984 Mar 17;1(8377):624-5. No abstract available.

PMID:
6142324
44.

Pertussis component vaccine in Japan.

Preston NW.

Lancet. 1984 Feb 25;1(8374):456. No abstract available.

PMID:
6142187
45.

Pertussis antibodies in vaccinated children.

Preston NW.

Lancet. 1983 Nov 19;2(8360):1197. No abstract available.

PMID:
6139553
46.

Toxicity of pertussis vaccine.

Preston NW.

Br Med J (Clin Res Ed). 1982 Jun 19;284(6332):1817-8. No abstract available.

47.

Whooping cough vaccine efficacy.

Preston NW.

Lancet. 1982 Apr 10;1(8276):860. No abstract available.

PMID:
6122091
48.

A reappraisal of serotype factors 4, 5 and 6 of Bordetella pertussis.

Preston NW, Surapatana N, Carter EJ.

J Hyg (Lond). 1982 Feb;88(1):39-46.

49.

Campylobacter serotypes and epidemiology.

Preston NW.

Lancet. 1981 Dec 5;2(8258):1283. No abstract available.

PMID:
6118691
50.

Pulmonary pertussis infection in the mouse: no solution to an old problem.

Carter EJ, Preston NW.

J Infect. 1981 Mar;3(1):86-8. No abstract available.

PMID:
7185947

Supplemental Content

Loading ...
Support Center